ReviewFamilial cancer2006
Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.
Review in Familial cancer, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial.Orphanet journal of rare diseases · 2013Trial
- Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome.Familial cancer · 2023Review
- Review
- Prevalence and endoscopic treatment outcomes of upper gastrointestinal neoplasms in familial adenomatous polyposis.Surgical endoscopy · 2022Article
- Prevalence of Gastroduodenal Polyps in Children With Familial Adenomatous Polyposis.Journal of the Canadian Association of Gastroenterology · 2021Article
- Increased prevalence of Barrett's esophagus in patients with MUTYH-associated polyposis (MAP).Familial cancer · 2020Article
- Upper gastrointestinal neoplasia in familial adenomatous polyposis: prevalence, endoscopic features and management.Journal of gastrointestinal oncology · 2019Article
- Genotype-phenotype correlation in 99 familial adenomatous polyposis patients: A prospective prevention protocol.Cancer medicine · 2019Article
- Feasibility of Cold Snare Polypectomy for Multiple Duodenal Adenomas in Patients with Familial Adenomatous Polyposis: A Pilot Study.Digestive diseases and sciences · 2016Article
- Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.Familial cancer · 2016Article
- Duodenal adenoma surveillance in patients with familial adenomatous polyposis.World journal of gastrointestinal endoscopy · 2015Review
- FAP related periampullary adenocarcinoma.International journal of surgery case reports · 2013Article
- Advanced duodenal disease in familial adenomatous polyposis: how frequently should patients be followed up after successful therapy?Familial cancer · 2012Article
- Endoscopic management of nonampullary duodenal polyps.Therapeutic advances in gastroenterology · 2012Article
- Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2011Review
- Progression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technology.Familial cancer · 2011Article
- Barrett esophagus with progression to adenocarcinoma in multiple family members with attenuated familial polyposis.Gastroenterology & hepatology · 2011Article
- Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in korean patients with familial adenomatous polyposis.Gut and liver · 2011Article
- FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.Familial cancer · 2010Article
- Hereditary and familial colon cancer.Gastroenterology · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Almost all patients affected by Familial Adenomatous polyposis (FAP) will develop foregut as well as hindgut polyps, and following prophylactic colectomy duodenal cancer constitutes one of the leading causes of death in screened populations. Without prophylactic colectomy, FAP patients predictably develop colorectal cancer, but the lifetime risk of upper gastrointestinal cancer is lower, estimated at approximately 5%. Management of the upper gastrointestinal cancer risk is one of the greatest challenges facing clinicians involved in the care of Polyposis families, and with improved survival following prophylactic colectomy, the burden of foregut disease (particularly duodenal adenomatosis) will increase. Until recently, the value of upper gastrointestinal surveillance in FAP populations has been contentious, but with improved understanding of the natural history coupled with developments in surgery, interventional endoscopy and medical therapy, treatment algorithms for duodenal adenomatosis in FAP are becoming clearer.
Indexed as
Identifiers
16998672What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.